REQUEST A DEMO
Total
USD $0.00
Search more companies

Mega Lifesciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Mega Lifesciences Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Mega Lifesciences Private Limited is a company based in India, with its head office in Thane. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on April 05, 2004. In its most recent financial highlights, the company reported a net sales revenue increase of 29.33% in 2025. Its’ total assets recorded a growth of 18.35%. The net profit margin of Mega Lifesciences Private Limited decreased by 0.17% in 2025.

Legal Address
A-1301, 13Th Floor, Thane One, Dil Complex Ghodbunder Road, Majiwada
Thane; Maharashtra; Postal Code: 400610

Contact Details: Purchase the Mega Lifesciences Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Mega Lifesciences Private Limited report to view the information.
Financial Auditors:
Purchase the Mega Lifesciences Private Limited report to view the information.
Incorporation Date:
April 05, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after Mega Lifesciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
29.33%
Total Operating Revenue
29.56%
Operating Profit
27.5%
EBITDA
36.66%
Net Profit/Loss for the Period
27.58%
Total Assets
18.35%
Total Equity
15.17%
Operating Profit Margin
-0.24%
Net Profit Margin
-0.17%
Return on Equity (ROE)
2.89%
Quick Ratio
-0.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?